The Spectrum of Infections in Patients with Lung Cancer

References

• World Health Organization (WHO). Cancer [accessed 2021 Apr 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.
   Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi:10.1007/978-3-319-24223-1_1.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Canales J, Parra-Cuentas E, Wistuba II. Diagnosis and molecular classification of lung cancer. Cancer Treat Res. 2016;170:25–46. doi:10.1007/978-3-319-40389-2_2.
   Google Scholar
• Zembower TR. Epidemiology of infections in cancer patients. Cancer Treat Res. 2014;161:43–89. doi:10.1007/978-3-319-04220-6_2.
   PubMedGoogle Scholar
• Sameer Nasir S, Muthiah M, Ryder K, Clark K, Niell H, Weir A. ICU deaths in patients with advanced cancer: reasonable criteria to decrease potentially inappropriate admissions and lack of benefit of advance planning discussions. Am J Hosp Palliat Care. 2017;34(2):173–179. doi:10.1177/1049909115625279.
   PubMed Web of Science ®Google Scholar
• Akinosoglou KS, Karkoulias K, Marangos M. Infectious complications in patients with lung cancer. Eur Rev Med Pharmacol Sci. 2013;17(1):8–18.
   PubMed Web of Science ®Google Scholar
• Perlin E, Bang KM, Shah A, Hursey PD, Whittingham WL, Hashmi K, et al. The impact of pulmonary infections on the survival of lung cancer patients. Cancer. 1990;66(3):593–596. doi:10.1002/1097-0142(19900801)66:3<593::AID-CNCR2820660331>3.0.CO;2-R.
   PubMed Web of Science ®Google Scholar
• EKMUD Rehberleri - EKMUD [accessed 2021 Apr 12]. Available from: https://www.ekmud.org.tr/emek/rehberler/1-ekmud-rehberleri.
   Google Scholar
• Markanday A. Acute phase reactants in infections: evidence-based review and a guide for clinicians. Open Forum Infect Dis. 2015;2(3):ofv098.
   PubMed Web of Science ®Google Scholar
• Addeo A, Obeid M, Friedlaender A. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. J Immunother Cancer. 2020;8(1):e000892. doi:10.1136/jitc-2020-000892.
   PubMed Web of Science ®Google Scholar
• Seo SK. Infectious complications of lung cancer. Oncology. 2005;19(2):185–194.
   PubMed Web of Science ®Google Scholar
• McDonald CF, Atkins RC. Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer. Chest. 1990;98(4):881–885. doi:10.1378/chest.98.4.881.
   PubMed Web of Science ®Google Scholar
• Lee KA, Luong MK, Shaw H, Nathan P, Bataille V, Spector TD. The gut microbiome: what the oncologist ought to know. Br J Cancer. 2021;125(9):1197–1209. doi:10.1038/s41416-021-01467-x.
   PubMed Web of Science ®Google Scholar
• Rolston KV. Infections in cancer patients with solid tumors: a review. Infect Dis Ther. 2017;6(1):69–83. doi:10.1007/s40121-017-0146-1.
   PubMed Web of Science ®Google Scholar
• Sarıhan S, Ercan I, Saran A, Cetintas K, Akalın H, Engin K. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev. 2005;29(2):181–188. doi:10.1016/j.cdp.2004.11.001.
   PubMedGoogle Scholar
• Berghmans T, Sculier P, Klastersky J. A prospective study of infections in lung cancer patients admitted to the hospital. Chest. 2003;124(1):114–120. doi:10.1378/chest.124.1.114.
   PubMed Web of Science ®Google Scholar
• Valvani A, Martin A, Devarajan A, Chandy D. Postobstructive pneumonia in lung cancer. Ann Transl Med. 2019;7(15):357. doi:10.21037/atm.2019.05.26.
   PubMed Web of Science ®Google Scholar
• Rolston KVI, Nesher L. Post-obstructive pneumonia in patients with cancer: a review. Infect Dis Ther. 2018;7(1):29–38. doi:10.1007/s40121-018-0185-2.
   PubMed Web of Science ®Google Scholar
• Abers MS, Sandvall BP, Sampath R, Zuno C, Uy N, Yu VL, et al. Postobstructive pneumonia: an underdescribed syndrome. Clin Infect Dis. 2016;62(8):957–961. doi:10.1093/cid/civ1212.
   PubMed Web of Science ®Google Scholar
• Rolston KV. Postobstructive pneumonia in cancer patients. Clin Infect Dis. 2016;63(5):707–708. doi:10.1093/cid/ciw368.
   PubMed Web of Science ®Google Scholar
• Ernst A, Silvestri GA, Johnstone D. Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest. 2003;123(5):1693–1717. doi:10.1378/chest.123.5.1693.
   PubMed Web of Science ®Google Scholar
• Mehta RM, Cutaia M. The role of interventional pulmonary procedures in the management of post-obstructive pneumonia. Curr Infect Dis Rep. 2006;8(3):207–214. doi:10.1007/s11908-006-0061-1.
   PubMedGoogle Scholar
• Torres A, Ferrer M. Editorial commentary: distinguishing postobstructive lung infection from community-acquired pneumonia. Clin Infect Dis. 2016;62(8):962–963. doi:10.1093/cid/civ1218.
   PubMed Web of Science ®Google Scholar
• Hsu-Kim C, Hoag JB, Cheng GS, Lund ME. The microbiology of postobstructive pneumonia in lung cancer patients. J Bronchology Interv Pulmonol. 2013;20(3):266–270. doi:10.1097/LBR.0b013e31829ddf01.
   PubMedGoogle Scholar
• Evans SE, Xu Y, Tuvim MJ, Dickey BF. Inducible innate resistance of lung epithelium to infection. Annu Rev Physiol. 2010;72:413–435. doi:10.1146/annurev-physiol-021909-135909.
   PubMed Web of Science ®Google Scholar
• Liao WY, Liaw YS, Wang HC, Chen KY, Luh KT, Yang PC. Bacteriology of infected cavitating lung tumor. Am J Respir Crit Care Med. 2000;161(5):1750–1753. doi:10.1164/ajrccm.161.5.9905103.
   PubMed Web of Science ®Google Scholar
• Dalar L, Özdemir C, Abul Y, Karasulu L, Sökücü SN, Akbaş A, Altn S. Therapeutic bronchoscopic interventions for malignant airway obstruction: a retrospective study from experience on 547 patients. Medicine. 2016;95(23):e3886. doi:10.1097/MD.0000000000003886.
   PubMed Web of Science ®Google Scholar
• Tremblay A, Marquette CH. Endobronchial electrocautery and argon plasma coagulation: a practical approach. Can Respir J. 2004;11(4):305–310. doi:10.1155/2004/216243.
   PubMedGoogle Scholar
• Mandell LA, Niederman MS. Aspiration pneumonia. N Engl J Med. 2019;380(7):651–663. doi:10.1056/NEJMra1714562.
   PubMed Web of Science ®Google Scholar
• Filaire M, Mom T, Laurent S, Harouna Y, Naamee A, Vallet L, et al. Vocal cord dysfunction after left lung resection for cancer. Eur J Cardiothorac Surg. 2001;20(4):705–711. doi:10.1016/s1010-7940(01)00819-3.
   PubMed Web of Science ®Google Scholar
• Taylor JK, Fleming GB, Singanayagam A, Hill AT, Chalmers JD. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med. 2013;126(11):995–1001. doi:10.1016/j.amjmed.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Chai YJ, Lee JM, Seong YW, Moon HJ. Application of continuous intraoperative neuromonitoring during VATS lobectomy for left lung cancer to prevent recurrent laryngeal nerve injury. Sci Rep. 2020;10(1):4636. doi:10.1038/s41598-020-61500-6.
   PubMed Web of Science ®Google Scholar
• Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;13(4):218–223. doi:10.1097/00001622-200107000-00002.
   PubMed Web of Science ®Google Scholar
• Imperatori A, Nardecchia E, Dominioni L, Sambucci D, Spampatti S, Feliciotti G, Rotolo N. Surgical site infections after lung resection: a prospective study of risk factors in 1,091 consecutive patients. J Thorac Dis. 2017;9(9):3222–3231. doi:10.21037/jtd.2017.08.122.
   PubMed Web of Science ®Google Scholar
• Simonsen DF, Søgaard M, Bozi I, Horsburgh CR, Thomsen RW. Risk factors for postoperative pneumonia after lung cancer surgery and impact of pneumonia on survival. Respir Med. 2015;109(10):1340–1346. doi:10.1016/j.rmed.2015.07.008.
   PubMed Web of Science ®Google Scholar
• Schussler O, Alifano M, Dermine H, Strano S, Casetta A, Sepulveda S, et al. Postoperative pneumonia after major lung resection. Am J Respir Crit Care Med. 2006;173(10):1161–1169. doi:10.1164/rccm.200510-1556OC.
   PubMed Web of Science ®Google Scholar
• Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from the Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135(2):247–254. doi:10.1016/j.jtcvs.2007.07.060.
   PubMed Web of Science ®Google Scholar
• Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322–330. doi:10.1086/505220.
   PubMed Web of Science ®Google Scholar
• Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest. 1994;105(3):760–766. doi:10.1378/chest.105.3.760.
   PubMed Web of Science ®Google Scholar
• Stéphan F, Boucheseiche S, Hollande J, Flahault A, Cheffi A, Bazelly B, Bonnet F. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000;118(5):1263–1270. doi:10.1378/chest.118.5.1263.
   PubMed Web of Science ®Google Scholar
• Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med. 2015;21(3):260–271. doi:10.1097/MCP.0000000000000156.
   PubMed Web of Science ®Google Scholar
• Gudiol C, Royo-Cebrecos C, Laporte J, Ardanuy C, Garcia-Vidal C, Antonio M, et al. Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients. Respirology. 2016;21(8):1411–1418. doi:10.1111/resp.12848.
   PubMed Web of Science ®Google Scholar
• Klastersky J, Aoun M. Opportunistic infections in patients with cancer. Ann Oncol. 2004;15(4):329–335.
   Web of Science ®Google Scholar
• Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015;26(1):21–33. doi:10.1093/annonc/mdu192.
   PubMed Web of Science ®Google Scholar
• Bavaro DF, Pizzutilo P, Catino A, Signorile F, Pesola F, Di Gennaro F, et al. Incidence of infections and predictors of mortality during checkpoint inhibitor immunotherapy in patients with advanced lung cancer: a retrospective cohort study. Open Forum Infect Dis. 2021;13:8(6):ofab187.
   Google Scholar
• Fujita K, Kim YH, Kanai O, Yoshida H, Mio T, Hirai T. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy. Respir Med. 2019;146:66–70. doi:10.1016/j.rmed.2018.11.021.
   PubMed Web of Science ®Google Scholar
• Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, et al. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016;54:139–148. doi:10.1016/j.ejca.2015.11.016.
   PubMed Web of Science ®Google Scholar
• Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, et al. Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management. Cancer Treat Rev. 2017;58:70–76. doi:10.1016/j.ctrv.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Xu C, Chen YP, Du XJ, Liu JQ, Huang CL, Chen L, et al. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis. BMJ. 2018;363:k4226. doi:10.1136/bmj.k4226.
   PubMed Web of Science ®Google Scholar
• Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137(1):223–230. doi:10.1016/j.jaci.2015.09.025.
   PubMed Web of Science ®Google Scholar
• Ogishi M, Yang R, Aytekin C, Langlais D, Bourgey M, Khan T, et al. Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child. Nat Med. 2021;27(9):1646–1654. doi:10.1038/s41591-021-01388-5.
   PubMed Web of Science ®Google Scholar
• Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol. 2011;186(3):1598–1607. doi:10.4049/jimmunol.1003304.
   PubMed Web of Science ®Google Scholar
• Chu YC, Fang KC, Chen HC, Yeh YC, Tseng CE, Chou TY, Lai CL. Pericardial tamponade caused by a hypersensitivity response to tuberculosis reactivation after anti-PD-1 treatment in a patient with advanced pulmonary adenocarcinoma. J Thorac Oncol. 2017;12(8):e111–e114. doi:10.1016/j.jtho.2017.03.012.
   PubMedGoogle Scholar
• Fujita K, Terashima T, Mio T. Anti-PD1 antibody treatment and the development of acute pulmonary tuberculosis. J Thorac Oncol. 2016;11(12):2238–2240. doi:10.1016/j.jtho.2016.07.006.
   PubMed Web of Science ®Google Scholar
• Del Castillo M, Romero FA, Argüello E, Kyi C, Postow MA, Redelman-Sidi G. The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma. Clin Infect Dis. 2016;63(11):1490–1493. doi:10.1093/cid/ciw539.
   PubMed Web of Science ®Google Scholar
• Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, et al. Impact of checkpoint inhibitor immunotherapy, primarily pembrolizumab, on infection risk in patients with advanced lung cancer: a comparative retrospective cohort study. Clin Infect Dis. 2021;73(9):e2697–e2704. doi:10.1093/cid/ciaa802.
   PubMed Web of Science ®Google Scholar
• Redelman-Sidi G, Michielin O, Cervera C, Ribi C, Aguado JM, Fernández-Ruiz M, Manuel O. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors). Clin Microbiol Infect. 2018;24:S95–S107. doi:10.1016/j.cmi.2018.01.030.
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Kuchiba A, Koyama T, Machida R, Shimomura A, Kitano S, et al. Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials. ESMO Open. 2020;5(2):e000653. doi:10.1136/esmoopen-2019-000653.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540–1550. doi:10.1016/S0140-6736(15)01281-7.
   PubMed Web of Science ®Google Scholar
• Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, et al. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol. 2015;16(3):257–265. doi:10.1016/S1470-2045(15)70054-9.
   PubMed Web of Science ®Google Scholar
• Kanjanapan Y, Yip D. Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy. Cancer Med. 2020; 9(23):9027–9035. doi:10.1002/cam4.3532.
   PubMed Web of Science ®Google Scholar
• Karam JD, Noel N, Voisin AL, Lanoy E, Michot JM, Lambotte O. Infectious complications in patients treated with immune checkpoint inhibitors. Eur J Cancer. 2020;141:137–142. doi:10.1016/j.ejca.2020.09.025.
   PubMed Web of Science ®Google Scholar
• Morelli T, Fujita K, Redelman-Sidi G, Elkington PT. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022;77(3):304–311. doi:10.1136/thoraxjnl-2021-217260.
   PubMed Web of Science ®Google Scholar
• Viscoli C, Castagnola E. Prophylaxis and empirical therapy of infection in cancer patients. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Doublas, and Bennett’s principle and practice of infectious diseases. Philadelphia (PA): Churchill Livingstone; 2009. p. 3793–3808.
   Google Scholar
• Donnelly JP, Blijlevens NMA, De Pauw BE. Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia (PA): Churchill Livingstone; 2009. p. 3781–3792.
   Google Scholar
• José RJ, Brown JS. Opportunistic bacterial, viral and fungal infections of the lung. Medicine. 2016;44(6):378–383. doi:10.1016/j.mpmed.2016.03.015.
   Google Scholar
• Yoo SS, Cha SI, Shin KM, Lee SY, Kim CH, Park JY, Jung TH. Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors. Scand J Infect Dis. 2010;42(10):734–740. doi:10.3109/00365548.2010.489569.
   PubMed Web of Science ®Google Scholar
• Wong JL, Evans SE. Bacterial pneumonia in patients with cancer: novel risk factors and management. Clin Chest Med. 2017;38(2):263–277. doi:10.1016/j.ccm.2016.12.005.
   PubMed Web of Science ®Google Scholar
• D'Journo XB, Rolain JM, Doddoli C, Raoult D, Thomas PA. Airways colonizations in patients undergoing lung cancer surgery. Eur J Cardiothorac Surg. 2011;40(2):309–319. doi:10.1016/j.ejcts.2010.11.036.
   PubMedGoogle Scholar
• Laroumagne S, Salinas-Pineda A, Hermant C, Murris M, Gourraud PA, Do C, et al. Incidence et caractéristiques des colonisations des voies respiratoires lors du diagnostic de cancer bronchique: étude rétrospective de 388 cas [Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases]. Rev Mal Respir. 2011;28(3):328–335. doi:10.1016/j.rmr.2010.05.020.
   PubMed Web of Science ®Google Scholar
• Laroumagne S, Lepage B, Hermant C, Plat G, Phelippeau M, Bigay-Game L, et al. Bronchial colonisation in patients with lung cancer: a prospective study. Eur Respir J. 2013;42(1):220–229. doi:10.1183/09031936.00062212.
   PubMed Web of Science ®Google Scholar
• Speert DP. Bacterial infections of the lung in normal and immunodeficient patients. Novartis Found Symp. 2006;279:42–51.
   PubMedGoogle Scholar
• Ruckdeschel JC, Greene J, Sommers KE, Karen KF. Respiratory infections in patients with cancer. In: Kufe DW, Pollock RE, Weichselbaum RR, editors. Holland-Frei cancer medicine. 6th ed. Hamilton (ON): BC Decker; 2003. Available from: https://www.ncbi.nlm.nih.gov/books/NBK13540/.
   Google Scholar
• Engels EA, Shen M, Chapman RS, Pfeiffer RM, Yu YY, He X, Lan Q. Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. Int J Cancer. 2009;124(5):1183–1187. doi:10.1002/ijc.24042.
   PubMed Web of Science ®Google Scholar
• Bhatt M, Kant S, Bhaskar R. Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J Cancer. 2012;1(1):36–42. doi:10.4103/2278-330X.96507.
   PubMedGoogle Scholar
• Brenner DR, McLaughlin JR, Hung RJ. Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011;6(3):e17479. doi:10.1371/journal.pone.0017479.
   PubMed Web of Science ®Google Scholar
• Keikha M, Esfahani BN. The relationship between tuberculosis and lung cancer. Adv Biomed Res. 2018;7:58. doi:10.4103/abr.abr_182_17.
   PubMedGoogle Scholar
• Oh CM, Roh YH, Lim D, Kong HJ, Cho H, Hwangbo B, et al. Pulmonary tuberculosis is associated with elevated risk of lung cancer in Korea: the Nationwide Cohort Study. J Cancer. 2020;11(7):1899–1906. doi:10.7150/jca.37022.
   PubMed Web of Science ®Google Scholar
• Chai M, Shi Q. The effect of anti-cancer and anti-tuberculosis treatments in lung cancer patients with active tuberculosis: a retrospective analysis. BMC Cancer. 2020;20(1):1121. doi:10.1186/s12885-020-07622-6.
   PubMed Web of Science ®Google Scholar
• Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–282. doi:10.1128/CMR.19.2.259-282.2006.
   PubMed Web of Science ®Google Scholar
• Raziq F, Usama M. Nocardiosis presenting like a metastatic lung cancer. Chest. 2020;158(4):A1600. doi:10.1016/j.chest.2020.08.1439.
   Web of Science ®Google Scholar
• Miyaoka C, Nakamoto K, Shirai T, Miyamoto M, Sasaki Y, Ohta K. Pulmonary nocardiosis caused by Nocardia exalbida mimicking lung cancer. Respirol Case Rep. 2019;7(7):e00458. doi:10.1002/rcr2.458.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis. 2013;56(2):258–266. doi:10.1093/cid/cis844.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Guthrie KA, Waghmare A, Walsh EE, Falsey AR, Kuypers J, et al. Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. J Infect Dis. 2014;209(8):1195–1204. doi:10.1093/infdis/jit832.
   PubMedGoogle Scholar
• Weng CF, Chen LJ, Lin CW, Chen HM, Lee HH, Ling TY, Hsiao FY. Association between the risk of lung cancer and influenza: a population-based nested case-control study. Int J Infect Dis. 2019;88:8–13. doi:10.1016/j.ijid.2019.07.030.
   PubMed Web of Science ®Google Scholar
• Tantawy AA, Barakat MM, Adly AA, Ebeid FS, Shamaa MF, Yassin M. One-year prospective study of community acquired influenza and parainfluenza viral infections in hospitalized Egyptian children with malignancy: single center experience. Pediatr Hematol Oncol. 2015;32(5):304–314. doi:10.3109/08880018.2015.1013230.
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362(9397):1733–1745. doi:10.1016/S0140-6736(03)14854-4.
   PubMed Web of Science ®Google Scholar
• Martino R, Porras RP, Rabella N, Williams JV, Rámila E, Margall N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant. 2005;11(10):781–796. doi:10.1016/j.bbmt.2005.07.007.
   PubMed Web of Science ®Google Scholar
• Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev. 2003;16(2):242–264. doi:10.1128/CMR.16.2.242-264.2003.
   PubMed Web of Science ®Google Scholar
• Rogado J, Pangua C, Serrano-Montero G, Obispo B, Marino AM, Pérez-Pérez M, et al. Covid-19 and lung cancer: a greater fatality rate? Lung Cancer. 2020;146:19–22. doi:10.1016/j.lungcan.2020.05.034.
   PubMed Web of Science ®Google Scholar
• Passaro A, Bestvina C, Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021;9(3):e002266. doi:10.1136/jitc-2020-002266.
   PubMed Web of Science ®Google Scholar
• Wu M, Mou R, Liu X, Guo S, Kong F, Li X, Jia Y. Is COVID-19 a high risk factor for lung cancer?: a protocol for systematic review and meta-analysis. Medicine. 2021;100(1):e23877. doi:10.1097/MD.0000000000023877.
   PubMedGoogle Scholar
• Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386–1396. doi:10.1016/j.annonc.2020.06.007.
   PubMed Web of Science ®Google Scholar
• Tao SL, Wang XM, Feng YG, Kang PM, Li QY, Sun TY, et al. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer? Med Hypotheses. 2020;143:110074. doi:10.1016/j.mehy.2020.110074.
   PubMed Web of Science ®Google Scholar
• Crumpacker CS. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. Vol 2. Philadelphia (PA): Churchill Livingstone; 2000. p. 1586–1599.
   Google Scholar
• Hasegawa Y, Ando M, Kubo A, Isa S, Yamamoto S, Tsujino K, et al. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer. 2014;83(1):8–13. doi:10.1016/j.lungcan.2013.10.002.
   PubMed Web of Science ®Google Scholar
• Angarone M. Fungal infections in cancer patients. Cancer Treat Res. 2014;161:129–155. doi:10.1007/978-3-319-04220-6_4.
   PubMedGoogle Scholar
• Velcheti V, Govindan R. Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen. Lung Cancer. 2007;57(2):240–242. doi:10.1016/j.lungcan.2007.02.010.
   PubMed Web of Science ®Google Scholar
• Lee EH, Park JE, Shin MH, Kim EY, Lee SH, Leem AY, et al. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer. Eur Respir J. 2018;52:PA4698. doi:10.1183/13993003.congress-2018.PA4698.
   Web of Science ®Google Scholar
• Liebling M, Rubio E, Ie S. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS? Expert Rev Respir Med. 2015;9(2):171–181. doi:10.1586/17476348.2015.1002471.
   PubMed Web of Science ®Google Scholar
• Probst M, Ries H, Schmidt-Wieland T, Serr A. Detection of Pneumocystis carinii DNA in patients with chronic lung diseases. Eur J Clin Microbiol Infect Dis. 2000;19(8):644–645. doi:10.1007/s100960000329.
   PubMed Web of Science ®Google Scholar
• Togashi Y, Masago K, Ito Y, Sakamori Y, Okuda C, Fukuhara A, et al. Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer. Oncol Lett. 2013;5(2):601–604. doi:10.3892/ol.2012.1052.
   PubMed Web of Science ®Google Scholar
• Takeda K, Harada S, Hayama B, Hoashi K, Enokida T, Sasaki T, et al. Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center. BMC Cancer. 2021;21(1):987. doi:10.1186/s12885-021-08727-2.
   PubMed Web of Science ®Google Scholar
• Doello K, Amezcua V, García J, Valdivia J. Pneumocystis jirovecii pneumonia in a non-small cell lung cancer patient on chemoradiotherapy: a case report. Saudi J Med Sci. 2020;8(1):53–55. doi:10.4103/sjmms.sjmms_255_18.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Patel AJ, Darr A, Jawad F, Steyn R. Aspergillus-related lung mass masquerading as a lung tumour. J Surg Case Rep. 2020;7:1–3.
   Google Scholar
• Vanfleteren M, Dingemans AC, Surmont VF, Vermaelen KY, Postma AA, Oude Lashof AML, et al. Invasive aspergillosis mimicking metastatic lung cancer. Front Oncol. 2018;8:188. doi:10.3389/fonc.2018.00188.
   PubMed Web of Science ®Google Scholar
• Carpagnano GE, Lacedonia D, Palladino GP, Logrieco G, Crisetti E, Susca A, et al. Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy. BMC Pulm Med. 2014;14:22. doi:10.1186/1471-2466-14-22.
   PubMed Web of Science ®Google Scholar
• Muzyka BC. Oral fungal infections. Dent Clin North Am. 2005;49(1):49–65, viii. doi:10.1016/j.cden.2004.07.007.
   PubMedGoogle Scholar
• McCarty TP, Pappas PG. Invasive candidiasis. Infect Dis Clin North Am. 2016;30(1):103–124. doi:10.1016/j.idc.2015.10.013.
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A, et al. Candida albicans and cancer: can this yeast induce cancer development or progression? Crit Rev Microbiol. 2016;42:182–193.
   Web of Science ®Google Scholar
• Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systemic review of the literature. Head Neck. 2009;31(9):1228–1239. doi:10.1002/hed.21140.
   PubMed Web of Science ®Google Scholar
• Vazquez JA, Sobel JD. Mucosal candidiasis. Infect Dis Clin North Am. 2002;16(4):793–820, v. doi:10.1016/S0891-5520(02)00042-9.
   PubMed Web of Science ®Google Scholar
• Severo CB, Guazzelli LS, Severo LC. Chapter 7: zygomycosis. J Bras Pneumol. 2010;36(1):134–141. doi:10.1590/s1806-37132010000100018.
   PubMed Web of Science ®Google Scholar
• Gazzoni FF, Severo LC, Marchiori E, Irion KL, Guimarães MD, Godoy MC, et al. Fungal diseases mimicking primary lung cancer: radiologic-pathologic correlation. Mycoses. 2014;57(4):197–208. doi:10.1111/myc.12150.
   PubMed Web of Science ®Google Scholar
• Severo CB, Gazzoni AF, Severo LC. Chapter 3 - pulmonary cryptococcosis. J Bras Pneumol. 2009;35(11):1136–1144. doi:10.1590/s1806-37132009001100012.
   PubMed Web of Science ®Google Scholar
• Ozkoc S, Bayram Akıüsü DS. C. Evaluation of pulmonary microsporidiosis in iatrogenically immunosuppressed patients. Tuberkuloz ve Toraks. 2016;64(1):9–16.
   PubMedGoogle Scholar
• Didier ES, Weiss LM. Microsporidiasis: not just in AIDS patients. Curr Opin Infect Dis. 2011;24(5):490–495. doi:10.1097/QCO.0b013e32834aa152.
   PubMed Web of Science ®Google Scholar
• Sartelli M. Surgical consideration of bacteria, fungi, and parasites. In: Galante JM, Coimbra R, editors. Thoracic surgery for the acute care surgeon. Hot topics in acute care surgery and trauma. Cham (Switzerland): Springer; 2021. p. 291–298.
   Google Scholar
• Hide G. Role of vertical transmission of Toxoplasma gondii in prevalence of infection. Expert Rev anti Infect Ther. 2016;14(3):335–344. doi:10.1586/14787210.2016.1146131.
   PubMed Web of Science ®Google Scholar
• Dubey J. Toxoplasmosis of animals and humans. Boca Raton (FL): CRC Press; 2010.
   Google Scholar
• Peng H, Chen X, Lindsay D. A review: competence, compromise, and concomitance-reaction of the host cell to Toxoplasma gondii infection and development. J Parasitol. 2011;97(4):620–628. doi:10.1645/GE-2712.1.
   PubMed Web of Science ®Google Scholar
• Bajnok J, Tarabulsi M, Carlin H, Bown K, Southworth T, Dungwa J, et al. High frequency of infection of lung cancer patients with the parasite Toxoplasma gondii. ERJ Open Res. 2019;5(2):00143–2018–2018. doi:10.1183/23120541.00143-2018.
   PubMedGoogle Scholar
• Princess I, Vadala R. Pleuropulmonary parasitic infections of present times-a brief review. J Microbiol Infect Dis. 2018;08(04):165–179. doi:10.5799/jmid.493861.
   Google Scholar
• Vanathy K, Parija SC, Mandal J, Hamide A, Krishnamurthy S. Cryptosporidiosis: a mini review. Trop Parasitol. 2017;7(2):72–80. doi:10.4103/tp.TP_25_17.
   PubMedGoogle Scholar
• Ulusan Bagci O, Guldaval F, Muftuoglu C, Mert U, Serce Unat D, Unat OS, et al. A pilot study on the evaluation of cryptosporidium infection in patients with lung cancer: respiratory cryptosporidiosis. Jpn J Infect Dis. 2022;75(6):569–574. doi:10.7883/yoken.JJID.2022.288.
   PubMedGoogle Scholar
• Kunst H, Mack D, Kon OM, Banerjee AK, Chiodini P, Grant A. Parasitic infections of the lung: a guide for the respiratory physician. Thorax. 2011;66(6):528–536. doi:10.1136/thx.2009.132217.
   PubMed Web of Science ®Google Scholar
• Bertolini F, De Matteis E, Malavasi N, Rossi G, Venturelli C, Codeluppi M, et al. Pulmonary strongyloidiasis mimicking cancer symptoms. Am J Clin Oncol. 2008;31(3):308–309. doi:10.1097/01.coc.0000217591.25973.b3.
   PubMed Web of Science ®Google Scholar